Optimum dose range for the amelioration of tong term radiation-induced hyposalivation using prophylactic pilocarpine treatment

Fred Ronald Burlage*, Judith M. Roesink, Hette Faber, Arjan Vissink, Johannes A. Langendijk, Harm H. Kampinga, Rob P. Coppes

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)

Abstract

Background: To determine dose and time dependency of pilocarpine pre-treatment protection from late damage after unilateral irradiation of the rat parotid gland.

Methods and materials: The right parotid gland of saline (1 mg/ml) or pilocarpine (4 mg/kg) pre-treated rats was irradiated with 10, 15 and 20 Gy. Saliva was collected from the irradiated and shielded parotid before, 30, 60, 120 and 240 days after irradiation. The number of acinar cells/gland was determined 30, 120 and 240 days after irradiation by histological examination.

Results: Pilocarpine pre-treated rats, protection of parotid gland function was seen in the early-intermediate phase (0-120 days) after 15 Gy and in the late phase (>120 days) after 10 and 15 Gy. Although no protection was observed after 20 Gy, a stimulatory effect of pilocarpine on the non-irradiated gland resulted in a significant increase in total saliva secretion.

The increase in function after pilocarpine treatment was paralleled by a significant increase in the number of acinar cells in both the irradiated and shielded glands.

Conclusions: Pre-irradiation treatment with pilocarpine induces compensatory response, at lower doses, in the irradiated and at higher doses in the non-irradiated gland reducing late damage, due to stimulation of unirradiated or surviving cells to divide. (c) 2007 Elsevier Ireland Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)347-353
Number of pages7
JournalRadiotherapy and Oncology
Volume86
Issue number3
DOIs
Publication statusPublished - Mar-2008

Keywords

  • pilocarpine
  • parotid gland
  • radiation-induced damage
  • radioprotection
  • SALIVARY-GLAND FUNCTION
  • PLACEBO-CONTROLLED TRIAL
  • RAT PAROTID-GLAND
  • NECK-CANCER
  • CONCOMITANT PILOCARPINE
  • DOUBLE-BLIND
  • HEAD
  • RADIOTHERAPY
  • IRRADIATION
  • XEROSTOMIA

Cite this